This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Purdue Pharmaceutical Products L.p., Proximagen Limited. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations by Claudio Festuccia in Cancer Treatments
Introduction
Claudio Festuccia, an esteemed inventor based in L'Aquila, Italy, has made significant contributions to the field of medicine, particularly in cancer treatment. With two notable patents to his name, Festuccia's work underscores the importance of innovation in addressing critical health challenges.
Latest Patents
Festuccia's latest inventions focus on advanced compounds for treating brain cancer. One of his patents introduces a compound of formula I, aimed at treating various types of brain cancers, including MGMT positive astrocytic brain tumors, metastatic brain cancers, and primary CNS lymphoma. This innovative compound holds the potential to improve treatment outcomes for patients suffering from these aggressive cancers.
Additionally, his research led to another patent concerning therapies for CNS cancers. This invention introduces a specific compound, 6-{4-[1-(Propan-2-yl)piperidin-4-yl]-1,4-diazepan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide, which can be used in combination with irradiation and chemotherapeutic agents to enhance the effectiveness of cancer treatments. The focus on combination therapies represents a promising advancement in the fight against cancer.
Career Highlights
Throughout his career, Claudio Festuccia has gained valuable experience working with reputable organizations, including Purdue Pharmaceutical Products L.P. and Proximagen Limited. His positions at these companies have helped refine his expertise in pharmaceutical innovations and pave the way for his groundbreaking patents.
Collaborations
Festuccia has also collaborated with notable professionals in the field, including Thomas Jorg Mehrling and Peter Richardson. These partnerships have been instrumental in driving forward his research and developing effective solutions for complex medical challenges.
Conclusion
Claudio Festuccia's innovative work in cancer treatment is a testament to the critical role inventors play in advancing medical science. His patents reflect a deep commitment to improving patient outcomes and highlight the ongoing need for innovation in healthcare. As research continues to evolve, Festuccia's contributions will undoubtedly inspire future developments in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile